Alira Health’s CDD Advises TVM Capital Healthcare Investment in neurocare Group AG

The financing represents TVM Capital Healthcare’s ongoing commitment to enhancing access to quality healthcare in the MENA region, marking its ninth investment toward this goal. neurocare’s innovative approach using its Digital Therapy Platform is designed to equip clinicians with the capability to administer personalized, sustainable treatments across various mental health conditions. The platform integrates neurostimulation with other technology-driven therapeutic tools and is currently utilized in neurocare’s clinics across the US, Europe, and Australia, as well as in an expanding network of third-party clinics.

With 13% of the global population affected by mental disorders, as reported by the World Health Organization, and an expected rise in related economic costs to $6 trillion by 2030, mental health care remains a critical global challenge. The COVID pandemic has notably exacerbated this issue, doubling the number of patients diagnosed with mental health conditions. Despite this increase, adequate treatment options remain scarce in most countries, underlining the importance of neurocare’s mission.

For more information, read the press release on the TVM Capital Healthcare website. To learn more about Alira Health’s commercial due diligence services, and other consulting and clinical services enabled by technology and real-world evidence, visit AliraHealth.com.